Symbiomics is a biotechnology company focused on developing high-performance biologicals containing efficient microbes for agriculture.
Symbiomics has raised $1.4M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Symbiomics's investors include The Yield Lab LATAM, Corteva Catalyst, Arar Capital, MOV Investimentos, Baraúna Venture Capital.
Symbiomics is headquartered in Florianópolis, Brazil.
Symbiomics is a biotechnology company focused on developing high-performance biologicals containing efficient microbes for agriculture.
Symbiomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Symbiomics — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/symbiomics. Accessed August 14, 2026.
VCBacked. (2025). Symbiomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/symbiomics
{{cite web |title=Symbiomics — Funding & Investors |url=https://www.vcbacked.co/company/symbiomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated